References
- Klein G, Boon T. Tumor immunology: present perspectives. Curr Opin Immunol 1993; 5: 687–92
- Swain SL. Lymphokines and the immune response: the central role of interleukin-2. Curr Opin Immunol 1991; 3: 304–10
- Rabinowich H, Vitolo D, Altarac S, Herberman R B, Whiteside TL. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2 activated natural killer cells. J Immunol 1992; 149: 340–9
- Lotze MT. T-cell growth factors and the treatment of patients with cancer. Clin Immunol Immunopathol 1992; 62: S47–54
- Rosenberg S A, Lotze M T, Yang G C, et al. Experience with the use of high-dose interleukin 2 in the treatment of 652 cancer patients. Ann Surg 1989; 210: 475–85
- Rivoltini L, Gambacorti-Passerini C, Massimo S-S, et al. In vivo interleukin 2-induced activation of lympho-kine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors. Cancer Res 1990; 50: 5551–7
- Whiteside T L, Letessier E, Hirabayashi H, et al. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck. Cancer Res 1993; 53: 5654–62
- Wong F S, Hibberd M L, Wen L, Millward B A, De-Maine AG. The human T cell receptor repertoire of normal peripheral blood lymphocytes before and after mitogen stimulation. Clin Exp Immunol 1993; 92: 361–6
- Kornfehl J, Neuchrist C, Grasl M C, Ehrenberger K, Kraft D, Scheiner O. The expression and cellular distribution of adhesion molecules CD2/LFA-3 and ICAM-1/LFA-l on mononuclear cells in squamous cell carcinoma of the head and neck. Eur Arch Otolaryngol 1993; 250: 1168–72
- Neuchrist C, Grasl M C, Scheiner O, Ehrenberger K, Lassman H, Kraft D. Phenotype of mononuclear phagocytes infiltrating squamous cell carcinomas of the head and neck. Br J Cancer 1991; 62: 7448–53
- Sacchi M, Klapan I, Johnson J, Whiteside TL. Antiproliferative effects of cytokines on squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1991; 117: 321–6
- Yasumura S, Hirabayashi H, Schwartz D R, et al. Human cytotoxic T-cell lines with restricted specificity for SCCHN. Cancer Res 1993; 53: 1461–8
- Cortesina G, Sacchi M, Galeazzi E, Johnson J T, Whiteside TL. Interleukin 2 receptors on squamous cell carcinomas of the head and neck. Acta Otolaryngol (Stockh) 1992; 112: 370–5
- Weidmann E, Sacchi M, Plaisance S, et al. Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ. Cancer Res 1992; 52: 5963–70
- Gallo O, Pinto S, Boccuzzi S, et al. Monocyte tumor necrosis factor production in head and neck squamous cell carcinoma. Laryngoscope 1992; 102: 447–50
- Parks R, Yan S D, Huang C-C. Tumor necrosis factor-alpha production in human head and neck squamous cell carcinoma. Laryngoscope 1994; 104: 860–4
- Pisa P, Halapi E, Pisa E K, et al. Selective expression of interleukin 10, interferon γ, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. PNAS 1992; 89: 7708–12
- Kazuki T, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992; 148: 1143–8
- UICC 1987. TNM classification of malignant tumors.4th ed. Springer Verlag, Berlin, Heidelberg, New York 1987
- Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning. A laboratory manual. Laboratory Press, Cold Spring Harbor 1989
- Van Kerckhove C, Russell G J, Deusch K, et al. Oligo-clonality of human intestinal intraepithelial T cells. J Exp Med 1992; 175: 57–63
- Hatakeyama M, Taniguchi T. Peptide growth factors and their receptors 1, MB Sporn, AB Roberts. Springer, New York 1990; 523
- Vassalli P. The pathophysiology of tumor necrosis factors. Ann Rev Immunol 1992; 10: 411–52
- Fiorentino D F, Zlotnik A, Mosmann T R, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815–20
- Klein E, Mantovani A. Action of natural killer cells and macrophages in cancer. Curr Opin Immunol 1993; 5: 714–8